FirsthandHealth
medRxiv PreprintsInternational29 October 2026

PharmaAgent: a real-world evaluation of high- and low-autonomy agentic systems for inpatient vancomycin dosing

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Vancomycin has a narrow therapeutic window requiring individualized dosing and repeated monitoring, a process health systems delegate from physicians to pharmacists for consistency. We silently deployed PharmaAgent, LLM-based vancomycin dosing agentic systems, at Stanford Hospital for two months and compared high- and low-autonomy configurations, each with and without institutional guidelines. Across 403 dosing events in 316 patients, mean absolute percentage error against the treating pharmacist's order was 21.8% with high autonomy versus 37.8% with low autonomy, and recommendations were with
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.